GlassScriptPhysician profile
Jerome A Swale
NPI 1669480844
$2,256.50
in general payments reported to CMS, 2019-2025
19 companies · $247 in 2025
The $247 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $328 · 2021: $468 · 2022: $217 · 2023: $362 · 2024: $422 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,031.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $800.87 | 2019-2025 | Centurion, Clareon, Hydrus Microstent |
| Allergan, INC. | $357.86 | 2020-2021 | |
| Abbvie INC. | $265.32 | 2022-2025 | Durysta, Vuity, Alphagan P |
| Rayner Intraocular Lenses Limited | $229.13 | 2022-2024 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Bausch & Lomb Americas INC. | $119.52 | 2023-2025 | Miebo, Vyzulta, Lotemax Sm |
| Sight Sciences, INC. | $97.65 | 2019-2024 | Omni Surgical System |
| Lensar, INC. | $58.25 | 2019-2024 | Lensar Laser System |
| Omeros Corporation | $50.12 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $47.36 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $43.56 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $40.94 | 2023-2024 | |
| Horizon Therapeutics Plc | $31.52 | 2023 | Tepezza |
| Biotissue Holdings INC. | $24.97 | 2019 | |
| Dompe US, INC. | $17.51 | 2021 | |
| Ivantis, INC | $17.39 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $15.65 | 2024 | Dextenza |
| Novartis Pharmaceuticals Corporation | $15.45 | 2019 | |
| Shire North American Group INC | $12.08 | 2019 | |
| Staar Surgical Company | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerome Swale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.